Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. (IST:ANGEN)
Turkey
· Delayed Price · Currency is TRY 9.81
+0.01 (0.10%)
At close: Jun 23, 2025, 6:00 PM GMT+3
IST:ANGEN Income Statement
Financials in millions TRY. Fiscal year is January - December.
Millions TRY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 537.57 | 529.83 | 343.92 | 468.38 | 410.11 | 421.56 |
| Revenue Growth (YoY) | 25.66% | 54.06% | -26.57% | 14.21% | -2.72% | - |
| Cost of Revenue | 219.26 | 195.26 | 69.4 | 66.77 | 51.43 | 48.23 |
| Gross Profit | 318.31 | 334.57 | 274.51 | 401.61 | 358.68 | 373.33 |
| Selling, General & Admin | 295.66 | 304.24 | 268.7 | 146.33 | 41.65 | 20.97 |
| Research & Development | 3.14 | 3.14 | 12.99 | 5.88 | 0.97 | 1.19 |
| Other Operating Expenses | 17.55 | 9.82 | 15.71 | -24.8 | 7.51 | 8.87 |
| Operating Expenses | 316.35 | 317.2 | 297.4 | 127.42 | 50.13 | 31.03 |
| Operating Income | 1.95 | 17.37 | -22.88 | 274.19 | 308.56 | 342.3 |
| Interest Expense | -3.91 | -3.26 | -4.87 | -3.49 | -53.17 | -1.63 |
| Interest & Investment Income | 7.46 | 17 | 67.94 | 102.75 | 10.17 | 1.66 |
| Currency Exchange Gain (Loss) | 49.27 | 70.33 | 272.27 | 294.25 | 196.7 | 17.38 |
| Other Non Operating Income (Expenses) | -232.96 | -266.62 | -468.45 | -593.41 | - | - |
| EBT Excluding Unusual Items | -178.19 | -165.18 | -155.99 | 74.29 | 462.26 | 359.71 |
| Gain (Loss) on Sale of Investments | -3.56 | -3.56 | -13.86 | - | - | - |
| Other Unusual Items | - | - | -41.11 | -28.47 | - | - |
| Pretax Income | -181.75 | -168.74 | -210.95 | 45.82 | 462.26 | 359.71 |
| Income Tax Expense | 59.33 | 50.14 | -13.63 | 55.88 | 18.88 | 43.93 |
| Earnings From Continuing Operations | -241.08 | -218.88 | -197.32 | -10.06 | 443.37 | 315.78 |
| Minority Interest in Earnings | - | - | - | -11.01 | -10.04 | -22.39 |
| Net Income | -241.08 | -218.88 | -197.32 | -21.06 | 433.33 | 293.4 |
| Net Income to Common | -241.08 | -218.88 | -197.32 | -21.06 | 433.33 | 293.4 |
| Net Income Growth | - | - | - | - | 47.70% | - |
| Shares Outstanding (Basic) | 220 | 220 | 220 | 220 | 151 | 151 |
| Shares Outstanding (Diluted) | 220 | 220 | 220 | 220 | 151 | 151 |
| Shares Change (YoY) | 0.07% | - | - | 45.28% | - | - |
| EPS (Basic) | -1.10 | -0.99 | -0.90 | -0.10 | 2.86 | 1.94 |
| EPS (Diluted) | -1.10 | -0.99 | -0.90 | -0.10 | 2.86 | 1.94 |
| EPS Growth | - | - | - | - | 47.70% | - |
| Free Cash Flow | -100.65 | -105.08 | 347.43 | 496.48 | 329.77 | 165.88 |
| Free Cash Flow Per Share | -0.46 | -0.48 | 1.58 | 2.26 | 2.18 | 1.09 |
| Dividend Per Share | - | - | - | 0.596 | - | - |
| Gross Margin | 59.21% | 63.15% | 79.82% | 85.74% | 87.46% | 88.56% |
| Operating Margin | 0.36% | 3.28% | -6.65% | 58.54% | 75.24% | 81.20% |
| Profit Margin | -44.85% | -41.31% | -57.38% | -4.50% | 105.66% | 69.60% |
| Free Cash Flow Margin | -18.72% | -19.83% | 101.02% | 106.00% | 80.41% | 39.35% |
| EBITDA | 102.47 | 113.6 | 53.1 | 331.36 | 318.29 | 347.29 |
| EBITDA Margin | 19.06% | 21.44% | 15.44% | 70.75% | 77.61% | 82.38% |
| D&A For EBITDA | 100.52 | 96.24 | 75.99 | 57.17 | 9.73 | 4.98 |
| EBIT | 1.95 | 17.37 | -22.88 | 274.19 | 308.56 | 342.3 |
| EBIT Margin | 0.36% | 3.28% | -6.65% | 58.54% | 75.24% | 81.20% |
| Effective Tax Rate | - | - | - | 121.94% | 4.08% | 12.21% |
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.